Cognitive Bias Modification Implementation Trial (CBM-IT)

Overview

Turning Point and Monash University, along with 20 partners, have been funded to conduct Australia’s first, real-world implementation study of Cognitive Bias Modification (CBM). CBM is a ‘brain-training’ intervention. which aims to reduce people’s automatic responses to alcohol cues to help improve their treatment outcomes.

In earlier trials, researcher-administered CBM delivered using a desktop computer and joystick during inpatient withdrawal treatment was shown to significantly reduce rates of relapse after discharge. Similarly, in our most recent nationwide trial, CBM delivered using a smartphone app was shown to help people in the community to reduce or stop drinking. The CBM-IT study will be the first to combine clinician-administered desktop with smartphone CBM post-discharge, with the aim of extending its beneficial effects.

The study will commence recruitment in 2027 through 14 inpatient withdrawal treatment sites across Australia. After completion of the project, we intend to publish the findings of this study in scientific journals and to present the findings at scientific conferences. We will also place a plain-language summary of the findings on this page of the Turning Point website and will include links to any publications that arise from the project on that page. Publicly presented data will only include numerical data and statistical analyses, and will not contain any information which may identify individual participants.

Project team

Primary Chief Investigator (PCI) - Prof Victoria Manning, Monash University, VIC

The study involves the following investigators and partners:

Chief Investigators

  • Prof Paul Haber, University of Sydney, NSW
  • Prof Dan Lubman, Monash University, VIC
  • Prof Patrick Olivier, Action Lab, Monash University, VIC
  • Prof Adrian Dunlop, Hunter New England Local Health District & University of Newcastle, NSW
  • Prof Kirsten Morely, University of Sydney, NSW
  • Prof Jessica Kasza, School of Public Health & Preventive Medicine, Monash University, VIC
  • Prof Catherine Mihalopolous, School of Public Health & Preventive Medicine, Monash University, VIC
  • Prof Malcolm Hopwood, University of Melbourne, VIC
  • Dr Alex Waddell, Monash University, VIC

Associate Investigators

  • Dr Ariel Roxburgh - Monash University
  • Assoc Prof Shalini Arunogiri - Monash University
  • Dr Robert Lundin - Deakin University
  • Dr David Plevin - The University of Adelaide
  • Assoc Prof Mark Daglish - Royal Brisbane and Women's Hospital
  • Prof Reinout Wiers - University of Amsterdam
  • Dr David Jacka - Monash Health
  • Assoc Prof David Pennington - University of California San Francisco
  • Assoc Prof Adam Searby - Monash University
  • Dr Mark Montebello - University of Sydney

Partners (sites)

  • Eastern Health, VIC
  • Western Health, VIC
  • Monash Health, VIC
  • Mildura Base Public Hospital, VIC
  • Uniting VicTas, VIC
  • Wyndham Clinic Private Hospital, VIC
  • The Melbourne Clinic, VIC
  • Ramsay Clinic Albert Road, VIC
  • Ramsay Clinic Adelaide, SA
  • Royal Brisbane and Women's Hospital, QLD
  • Royal Prince Alfred Hospital, NSW
  • Royal North Shore Hospital, NSW
  • Royal Perth Hospital Next Step, WA

Other Partners

  • Ramsay Hospital Research Foundation
  • Drug and Alcohol Nurses of Australasia (DANA)
  • Self Help Addiction Resource Centre (SHARC)
  • Hospitals Contribution Fund (HCF)
  • Victorian Alcohol and Drug Association (VAADA)
  • Department of Health Victoria
  • Turning Point, Eastern Health

Turning Point Team

  • Dr Joshua Garfield, Research Fellow
  • Dr Emily Colton, Research Fellow
  • Dr Jasmin Grigg, Senior Research Fellow, Implementation Science Lead
  • Ms Isabella Papadopoulos, PhD candidate

If you wish to contact the research team, please email us at [email protected]

Other Funder

The study has been funded by a Partnership Grant from the National Health and Medical Research Council (GNT 2044139) and by Ramsay Hospitals Research Foundation.